Steroid pulse -therapy in patients. With coronavirus Pneumonia (COVID-19), systemic inflammation And Risk of venous thrombosis and thromboembolism (WAYFARER Study)11 | Russia | 17 patients with severe coronavirus pneumonia using retrospective comparison analysis (control group, n = 17). | 34 patients with a proven diagnosis of coronavirus pneumonia who were admitted to the Medical Research and Educational Center of Lomonosov Moscow State University. | agents, it was decided to perform pulse treatment with high doses GCs: MP 1000 mg intravenously for 3 days with subsequent dexamethasone 4 mg twice a day for 3 - 7 days. | therapy with MP 1000 mg for 3 days and dexamethasone 8 mg for another 3 - 5 days | High-dose pulse GC therapy has a rapid anti-inflammatory effect; however, it increases the NLR and the D-dimer levels, which increase the risk of venous thromboembolism |